1-4 of 4
amplify-ext trial
Close
Sort by
Journal Articles

Direct Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism: A Systematic Review & Network Meta-Analysis

Mia Djulbegovic, MD, Alfred Lee, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4721.
https://doi.org/10.1182/blood.V130.Suppl_1.4721.4721
Published: 2017
Journal Articles

Extended Non-Vitamin K Antagonist Oral Anticoagulation Therapy for Prevention of Recurrent Venous Thromboembolism. a Review of Phase III and Phase IV Studies

Franco Piovella, MD, Diana I Iosub, MD
Journal: Blood
Blood (2016) 128 (22): 5011.
https://doi.org/10.1182/blood.V128.22.5011.5011
Published: 2016
Journal Articles

Comparison of Medical Costs Avoided When New Oral Anticoagulants Are Used for the Treatment of Patients with Atrial Fibrillation and Venous Thromboembolism in the U.S

Alpesh N Amin, MDMBA, Amanda Bruno, PhD MPH, Jeffrey Trocio, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD
Journal: Blood
Blood (2014) 124 (21): 2181.
https://doi.org/10.1182/blood.V124.21.2181.2181
Published: 2014
Journal Articles

Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial

Xianchen Liu, MD, PhD, John Thompson, PhD, Hemant Phatak, PhD, Jack Mardekian, PhD, Anthony R. Porcari, PhD, PharmD, Margot R. Johnson, MD, BSC
Journal: Blood
Blood (2013) 122 (21): 3638.
https://doi.org/10.1182/blood.V122.21.3638.3638
Published: 2013